STOCK TITAN
  1. Home
  2. CBLI

CBLI (CBLI) Stock Price, News & Analysis

CBLI NASDAQ

Company Description

CBLI (NASDAQ: CBLI) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for CBLI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
-7.31%

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

-7.74%

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

conferences earnings
-7.74%

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

earnings
-9.17%

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

-7.82%

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

-5.12%

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

conferences earnings

CBLI has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, earnings, covid-19, acquisition. View all CBLI news →

SEC Filings

View All

No SEC filings available for CBLI.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CBLI Company Profile & Sector Positioning

CBLI (CBLI) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.